Latest Urology News
Lower rate of VTE recurrence, but higher clinically relevant non-major bleeding versus dalteparin.
In a meta-analysis, smokers had an 89% greater risk of dying from prostate cancer compared with nonsmokers.
The approval of Yonsa was based on 2 randomized, placebo-controlled, multicenter Phase 3 studies in patients with mCRPC.
Cryoablation also cuts the need for opioids at 24 hours post-treatment and at 3 months.
Sharpest decrease seen in privately insured men after 2011.
Clinicians tend to focus on the number of voids, but patients worry more about interrupted sleep.
Magnitude of benefit of immune checkpoint inhibitors sex-dependent for patients with advanced cancers.
Compared with whites, blacks, and Hispanics, Middle Easterners are more likely to have predominantly calcium oxalate monohydrate stones, but less likely to have hydroxyapatite stones.
Enhanced therapeutic effect of bacillus Calmette-Gurin tx in non-muscle invasive bladder cancer.
Nine donations were confirmed positive; 6 of these had travelled to ZIKV-active areas.
Rather intermittent oxygen desaturation was associated with a 3% greater likelihood of nocturia.
Both younger age and more recent exposure to some antibiotics were associated with greater risks for kidney stones.
Findings show small increased risk with white wine, decreased risk with red wine
High PSA levels and larger number of positive biopsy cores are associated with positive surgical margins and extracapsular extension/seminal vesicle invasion after radical prostatectomy.
But majority of oncologists don't feel knowledgeable enough to make these recommendations
Women with type 2 diabetes have a 1.5-fold higher risk of renal cell carcinoma compared with non-diabetic women.
Men and women who smoke are at 2.3-fold and 2.7-fold increased risk of bladder cancer compared with non-smokers.
In clinical trials, the combination of Myrbetriq + solifenacin succinate was associated with greater improvements in the number of incontinence episodes per 24 hours (primary endpoint), the number of micturations per 24 hours (primary endpoint), and the volume voided per micturation (secondary endpoint) compared to placebo or to individual active components.
Instilling gemcitabine into the bladder immediately following resection of low-grade non-muscle-invasive bladder cancer significantly lowers recurrence risk.
The new statement emphasizes shared decision-making on screening for men aged 55 to 69 years who are at average risk for prostate cancer.
Renal and Urology News Articles
- Novel Blood Test Improves Detection of High-Grade Prostate Cancer
- Stone Composition Affects Nephrolithiasis Recurrence Rate
- Ultrasound Still Underused for Initial Imaging of Acute Renal Colic
- Hyperkalemia Drug Receives FDA Approval
- Post-op Intravesical Gemcitabine May Lower Bladder CA Recurrence Risk
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)